相关实验视频

Updated: May 9, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

完整的N-of-1试验设计在生物等效-生物类似药物开发中的应用

Yuqing Liu¹, Wendy Lou¹, Shein-Chung Chow²

¹Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Journal of biopharmaceutical statistics

|April 29, 2025

概括

完整的N-of-1试验设计与传统的交叉设计相比,为评估生物相似性提供了更有效的方法,特别是在复杂的多次治疗场景中. 这种方法最大限度地减少了估计差异,提高了生物类似药物评估的可靠性.

科学领域:

制药指标 (Pharmacometrics) 是一个指标.
生物统计学生物统计学
监管科学监管科学

背景情况:

生物类药物提高了获得生物疗法的机会,需要强有力的评估方法才能获得监管部门的批准.
目前的双处理交叉设计可能不足以进行多产品或多配方生物相似研究.
跨区域研究或评估不同剂量形式的桥梁研究带来了独特的评估挑战.

研究的目的:

为了比较生物类似性评估的多处理设计的统计效率.
评估完整的N-of-1试验设计与其他多处理设计的性能.
调查生物类似研究中样本大小和相对效率之间的关系.

主要方法:

采用线性混合效应模型来估计治疗效应对比.
调查了拉丁方形,威廉姆斯,平衡的不完整块和完整的N-of-1试验设计.
在一致的显著级别和功率下探索样本大小和相对效率.

主要成果:

完整的N-of-1设计在检查条件中显示了最低的估计方差.
与替代多处理设计相比,这种设计显示出更高的相对效率.
该研究为统计方法和多配方研究中的性能比较提供了一个框架.

结论:

完整的N-of-1试验设计是多重治疗场景中生物类似物评估的更有效和更可靠的方法.
这种设计解决了传统方法的局限性,特别是对于复杂的监管和制定挑战.
这些发现支持采用完整的N-of-1设计,以加强生物类似药物的开发和评估.

关键词:

完整的N-of-1试验设计.生物等价性生物等价性生物相似性生物相似性高级交叉路口设计.样本大小的确定样本大小的确定

更多相关视频

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

相关概念视频

Bioequivalence: Overview

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...